Terms: = Lymphoma AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18
45 results:
1. Treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
[TBL] [Abstract] [Full Text] [Related]
2. miR-539-5p targets BMP2 to regulate Treg activation in B-cell acute lymphoblastic leukemia through TGF-β/Smads/MAPK.
Dai Q; Shi R; Zhang G; Wang Y; Ye L; Peng L; Guo S; He J; Yang H; Jiang Y
Exp Biol Med (Maywood); 2024; 249():10111. PubMed ID: 38510491
[TBL] [Abstract] [Full Text] [Related]
3. Somatostatin Inhibited the EMT of Pancreatic Cancer Cells by Mediating the TGF-β/Smad Signaling Pathway.
Zhou X; Wang W; Liu L
Discov Med; 2023 Dec; 35(179):1086-1092. PubMed ID: 38058074
[TBL] [Abstract] [Full Text] [Related]
4. Expression of miR-223-3p in patients with hepatitis B virus liver fibrosis and its effect on hepatic stellate cells: An observational study.
Hu T; Zhang W; Xu C
Medicine (Baltimore); 2023 Jul; 102(30):e34454. PubMed ID: 37505133
[TBL] [Abstract] [Full Text] [Related]
5. Differential Reactivation of Cytomegalovirus and Epstein-Barr Virus in Patients with B Cell lymphoma.
Hatayama Y; Watanabe K; Ichikawa H; Kawamura K; Fukuda T; Motokura T
Viral Immunol; 2023 Oct; 36(8):520-525. PubMed ID: 37440168
[TBL] [Abstract] [Full Text] [Related]
6. Expression and prognostic role of STAT5a across cancer types.
Maninang C; Li J; Li WX
Biosci Rep; 2023 Aug; 43(8):. PubMed ID: 37369132
[TBL] [Abstract] [Full Text] [Related]
7. The β-catenin-LINC00183-miR-371b-5p-smad2/LEF1 axis promotes adult T-cell lymphoblastic lymphoma progression and chemoresistance.
Huang WJ; Guo SB; Shi H; Li XL; Zhu Y; Li M; Song LY; Yu RM; Cai QQ; Tian XP
J Exp Clin Cancer Res; 2023 Apr; 42(1):105. PubMed ID: 37106379
[TBL] [Abstract] [Full Text] [Related]
8. Galunisertib synergistically potentiates the doxorubicin-mediated antitumor effect and kickstarts the immune system against aggressive lymphoma.
Rej A; Paladhi A; Daripa S; Sarkar D; Bhattacharyya S; Mondal I; Hira SK
Int Immunopharmacol; 2023 Jan; 114():109521. PubMed ID: 36470118
[TBL] [Abstract] [Full Text] [Related]
9. Genistein alleviates renin-angiotensin system mediated vascular and kidney alterations in renovascular hypertensive rats.
Poasakate A; Maneesai P; Potue P; Bunbupha S; Tong-Un T; Settheetham-Ishida W; Khamseekaew J; Pakdeechote P
Biomed Pharmacother; 2022 Feb; 146():112601. PubMed ID: 35062067
[TBL] [Abstract] [Full Text] [Related]
10. TGF-β/IL-7 Chimeric Switch Receptor-Expressing CAR-T Cells Inhibit Recurrence of CD19-Positive B Cell lymphoma.
Noh KE; Lee JH; Choi SY; Jung NC; Nam JH; Oh JS; Song JY; Seo HG; Wang Y; Lee HS; Lim DS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445415
[TBL] [Abstract] [Full Text] [Related]
11. Suppression of latent transforming growth factor-β (TGF-β)-binding protein 1 (LTBP1) inhibits natural killer/ T cell lymphoma progression by inactivating the TGF-β/Smad and p38
Lin R; Li X; Wu S; Qian S; Hou H; Dong M; Zhang X; Zhang M
Exp Cell Res; 2021 Oct; 407(1):112790. PubMed ID: 34418460
[TBL] [Abstract] [Full Text] [Related]
12. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL).
Zarei-Ghobadi M; Sheikhi M; Teymoori-Rad M; Yaslianifard S; Norouzi M; Yaslianifard S; Faraji R; Farahmand M; Bayat S; Jafari M; Mozhgani SH
BMC Res Notes; 2021 Mar; 14(1):109. PubMed ID: 33757561
[TBL] [Abstract] [Full Text] [Related]
13. Support of BCP-ALL-cells by autologous bone marrow Th-cells involves induction of AID expression but not widespread AID off-target mutagenesis.
Traxel S; Lehmann J; Richard S; Sidorov S; Niggli F; Berger C; Nadal D; Bürgler S
Cancer Immunol Immunother; 2021 Aug; 70(8):2275-2289. PubMed ID: 33507341
[TBL] [Abstract] [Full Text] [Related]
14. Knockdown of long non‑coding RNA ANRIL inhibits the proliferation and promotes the apoptosis of Burkitt lymphoma cells through the TGF‑β1 signaling pathway.
Mao S; Jin J; Li Z; Yang W
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33325535
[TBL] [Abstract] [Full Text] [Related]
15. Bcl6 Suppresses Cardiac Fibroblast Activation and Function via Directly Binding to Smad4.
Ni J; Wu QQ; Liao HH; Fan D; Tang QZ
Curr Med Sci; 2019 Aug; 39(4):534-540. PubMed ID: 31346987
[TBL] [Abstract] [Full Text] [Related]
16. Inhibition of Interleukin 10 Transcription through the smad2/3 Signaling Pathway by Ca
Matsui M; Kajikuri J; Kito H; Endo K; Hasegawa Y; Murate S; Ohya S
Mol Pharmacol; 2019 Mar; 95(3):294-302. PubMed ID: 30622214
[TBL] [Abstract] [Full Text] [Related]
17. The Effects of Smad3 on Adrenocorticotropic Hormone-Secreting Pituitary Adenoma Development, Cell Proliferation, Apoptosis, and Hormone Secretion.
Zhou YZ; Li CZ; Gao H; Zhang YZ
World Neurosurg; 2018 Jun; 114():e329-e337. PubMed ID: 29524699
[TBL] [Abstract] [Full Text] [Related]
18. Decreasing Eukaryotic Initiation Factor 3C (EIF3C) Suppresses Proliferation and Stimulates Apoptosis in Breast Cancer Cell Lines Through Mammalian Target of Rapamycin (mTOR) Pathway.
Zhao W; Li X; Wang J; Wang C; Jia Y; Yuan S; Huang Y; Shi Y; Tong Z
Med Sci Monit; 2017 Aug; 23():4182-4191. PubMed ID: 28854163
[TBL] [Abstract] [Full Text] [Related]
19. CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.
Yokoyama M; Ichinoe M; Okina S; Sakurai Y; Nakada N; Yanagisawa N; Jiang SX; Numata Y; Umezawa A; Miyazaki K; Higashihara M; Murakumo Y
Int J Hematol; 2017 May; 105(5):614-622. PubMed ID: 28032275
[TBL] [Abstract] [Full Text] [Related]
20. Bcl-3 regulates TGFβ signaling by stabilizing Smad3 during breast cancer pulmonary metastasis.
Chen X; Cao X; Sun X; Lei R; Chen P; Zhao Y; Jiang Y; Yin J; Chen R; Ye D; Wang Q; Liu Z; Liu S; Cheng C; Mao J; Hou Y; Wang M; Siebenlist U; Eugene Chin Y; Wang Y; Cao L; Hu G; Zhang X
Cell Death Dis; 2016 Dec; 7(12):e2508. PubMed ID: 27906182
[TBL] [Abstract] [Full Text] [Related]
[Next]